Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials (Q79345406)
Jump to navigation
Jump to search
scientific article published on 09 November 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials |
scientific article published on 09 November 2006 |
Statements
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials (English)
Stadtmauer EA
Jagannath S
Richardson PG
Sonneveld P
Schuster MW
Irwin D
Facon T
Harousseau JL
Cowan JM
9 November 2006